These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 29218249)
1. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases. Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249 [TBL] [Abstract][Full Text] [Related]
2. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer. Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897 [TBL] [Abstract][Full Text] [Related]
5. Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells. Sanchez WY; de Veer SJ; Swedberg JE; Hong EJ; Reid JC; Walsh TP; Hooper JD; Hammond GL; Clements JA; Harris JM Endocrinology; 2012 Jul; 153(7):3179-89. PubMed ID: 22547569 [TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression. Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730 [TBL] [Abstract][Full Text] [Related]
7. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells. Shahinian H; Loessner D; Biniossek ML; Kizhakkedathu JN; Clements JA; Magdolen V; Schilling O Mol Oncol; 2014 Feb; 8(1):68-82. PubMed ID: 24120346 [TBL] [Abstract][Full Text] [Related]
8. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA. Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050 [TBL] [Abstract][Full Text] [Related]
9. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis. Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085 [TBL] [Abstract][Full Text] [Related]
10. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. Tripathi M; Nandana S; Yamashita H; Ganesan R; Kirchhofer D; Quaranta V J Biol Chem; 2008 Nov; 283(45):30576-84. PubMed ID: 18784072 [TBL] [Abstract][Full Text] [Related]
11. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Wilson S; Greer B; Hooper J; Zijlstra A; Walker B; Quigley J; Hawthorne S Biochem J; 2005 Jun; 388(Pt 3):967-72. PubMed ID: 15537383 [TBL] [Abstract][Full Text] [Related]
12. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. Lucas JM; True L; Hawley S; Matsumura M; Morrissey C; Vessella R; Nelson PS J Pathol; 2008 Jun; 215(2):118-25. PubMed ID: 18338334 [TBL] [Abstract][Full Text] [Related]
13. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes. Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268 [TBL] [Abstract][Full Text] [Related]
14. Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis. Falkowski K; Bielecka E; Thøgersen IB; Bocheńska O; Płaza K; Kalińska M; Sąsiadek L; Magoch M; Pęcak A; Wiśniewska M; Gruba N; Wysocka M; Wojtysiak A; Brzezińska-Bodal M; Sychowska K; Pejkovska A; Rehders M; Butler G; Overall CM; Brix K; Dubin G; Lesner A; Kozik A; Enghild JJ; Potempa J; Kantyka T Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575583 [TBL] [Abstract][Full Text] [Related]
16. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328 [TBL] [Abstract][Full Text] [Related]
17. Interdependence of kallikrein-related peptidases in proteolytic networks. Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517 [TBL] [Abstract][Full Text] [Related]
18. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Afar DE; Vivanco I; Hubert RS; Kuo J; Chen E; Saffran DC; Raitano AB; Jakobovits A Cancer Res; 2001 Feb; 61(4):1686-92. PubMed ID: 11245484 [TBL] [Abstract][Full Text] [Related]
19. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492 [TBL] [Abstract][Full Text] [Related]